Stocks and Investing Stocks and Investing
Fri, August 18, 2017
Thu, August 17, 2017

Amit Hazan Initiated (ABT) at Hold and Held Target at $53 on, Aug 17th, 2017


Published on 2024-10-25 22:25:42 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Citigroup, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $53 on, Aug 17th, 2017.

Amit has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 2 agree with Amit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017
  • Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017


These are the ratings of the 3 analyists that currently disagree with Amit


  • Brittany Henderson of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $56 on, Friday, July 21st, 2017
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $62 on, Friday, July 21st, 2017
  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017

Contributing Sources